Carl Zeiss Meditec AG is a multinational medical technology company and subsidiary of Carl Zeiss AG. It manufactures tools for eye examinations and medical lasers as well as solutions for neurosurgery, dentistry, gynecology and oncology. Among its products are the most common tools used by ophthalmologists and optometrists.
In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system.
Zeiss (/zaɪs/ ZYSE; German: [kaʁl ˈtsaɪs]) is a German manufacturer of optical systems and optoelectronics, founded in Jena, Germany, in 1846 by optician Carl Zeiss. Together with Ernst Abbe (joined 1866) and Otto Schott (joined 1884) he laid the foundation for today's multinational company. The current company emerged from a reunification of Carl Zeiss companies in East and West Germany with a consolidation phase in the 1990s. ZEISS is active in four business segments with approximately equal revenue (Industrial Quality and Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology) in almost 50 countries, has 30 production sites and around 25 development sites worldwide.
Carl Zeiss AG is the holding company for all subsidiaries within the Zeiss Group, of which Carl Zeiss Meditec AG is the only one that is traded on the stock market. Carl Zeiss AG is owned by the Carl-Zeiss-Stiftung foundation. The Zeiss Group has its headquarters in southern Germany, in the small town of Oberkochen, with its second largest, and founding site, being Jena in eastern Germany. Also controlled by the Carl-Zeiss-Stiftung is the glass manufacturer Schott AG, located in Mainz and Jena. Carl Zeiss is one of the oldest existing optics manufacturers in the world.